Evidence map›Paper›PMID 36589632›Full record

ArticleHealth science reports2023

Application of machine learning methods in predicting schizophrenia and bipolar disorders: A systematic review.

Mahdieh Montazeri, Mitra Montazeri, Kambiz Bahaadinbeigy, Mohadeseh Montazeri, Ali Afraz

Abstract read
In one paragraph

Article in Health science reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. [Risk Prediction Performance of Blood Biomarkers for Bipolar Disorder With Psychotic Symptoms].Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2025
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. How to Solve Clinical Challenges in Mood Disorders; Machine Learning Approaches Using Electrophysiological Markers.Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology · 2024
    Review
  11. Review
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mahdieh MontazeriDepartment of Health Information Sciences, Faculty of Management and Medical Information Sciences Kerman University of Medical Sciences Kerman Iran.ORCID 0000-0001-6987-6199
Mitra MontazeriMedical Informatics Research Center, Institute for Futures Studies in Health Kerman University of Medical Sciences Kerman Iran.
Kambiz BahaadinbeigyMedical Informatics Research Center, Institute for Futures Studies in Health Kerman University of Medical Sciences Kerman Iran.ORCID 0000-0002-5430-3758
Mohadeseh MontazeriDepartment of Computer, Faculty of Fatimah Kerman Branch Technical and Vocational University Kerman Iran.
Ali AfrazMedical Informatics Research Center, Institute for Futures Studies in Health Kerman University of Medical Sciences Kerman Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Aim: Schizophrenia and bipolar disorder (BD) are critical and high-risk inherited mental disorders with debilitating symptoms. Worldwide, 3% of the population suffers from these disorders. The mortality rate of these patients is higher compared to other people. Current procedures cannot effectively diagnose these disorders because it takes an average of 10 years from the onset of the first symptoms to the definitive diagnosis of the disease. Machine learning (ML) techniques are used to meet this need. This study aimed to summarize information on the use of ML techniques for predicting schizophrenia and BD to help early and timely diagnosis of the disease. Methods: A systematic literature search included articles published until January 19, 2020 in 3 databases. Two reviewers independently assessed original papers to determine eligibility for inclusion in this review. PRISMA guidelines were followed to conduct the study, and the Prediction Model Risk of Bias Assessment Tool (PROBAST) to assess included papers. Results: In this review, 1243 papers were retrieved through database searches, of which 15 papers were included based on full-text assessment. ML techniques were used to predict schizophrenia and BDs. The main algorithms applied were support vector machine (SVM) (10 studies), random forests (RF) (5 studies), and gradient boosting (GB) (3 studies). Input and output characteristics were very diverse and have been kept to enable future research. RFs algorithms demonstrated significantly higher accuracy and sensitivity than SVM and GB. GB demonstrated significantly higher specificity than SVM and RF. We found no significant difference between RF and SVM in terms of specificity. Conclusion: ML can precisely predict results and assist in making clinical decisions-concerning schizophrenia and BD. RF often performed better than other algorithms in supervised learning tasks. This study identified gaps in the literature and opportunities for future psychological ML research.

Indexed as

bipolarmachine learningpredictionschizophrenia

Identifiers

PMID36589632
PMCPMC9795991

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.